Uruguay’s Casmu Medical Center has signed an agreement with the Russian Direct Investment Fund (RDIF) to supply the country with 1.5 million doses of the Russian Sputnik V coronavirus vaccine. It is planned that after WHO approval, the drug will be available in January 2021. This was announced on Friday, November 20, by the president of the medical center Raul Rodriguez in an interview with radio Oriental…
“We signed an agreement and became the local representative of the Sputnik V vaccine <...> The company has reserved the vaccine for one and a half million people, two doses each,” he said.
Casmu is awaiting the completion of the third phase of clinical trials and WHO approval in order to begin distribution, Rodriguez said.
On November 19 it became known that the manufacturers of the Sputnik V vaccine submitted an application to the headquarters of the World Health Organization (WHO) for the certification of the drug. According to the WHO representative in Russia Melita Vuinovich, during a pandemic, vaccines undergo conditional certification first in the country of production, and then submit an application to Geneva, to the WHO headquarters.
On November 18, WHO Representative in Russia Melita Vujnovich said that WHO is optimistic about the recommendation of a Russian vaccine against coronavirus and a corresponding decision may be made in the near future.
On August 11, the world’s first coronavirus vaccine was registered in Russia. The drug was developed by specialists of the Center. N. Gamalei and was named “Sputnik V”. The Ministry of Health of the Russian Federation has already announced the launch of the vaccine into production and issued a permit for a post-registration study.